Article metrics
Other content recommended for you
- When the going gets tough: how to select patients with Parkinson's disease for advanced therapies
- Parkinson’s disease: etiopathogenesis and treatment
- Pharmacological treatment of Parkinson's disease
- Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease
- Initial drug treatment in Parkinson’s disease
- Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management
- Monoamine oxidase type B inhibitors in early Parkinson's disease: meta-analysis of 17 randomised trials involving 3525 patients
- ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson’s disease
- Dopamine agonists: their role in the treatment of Parkinson's disease
- Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels